WebMyers has served as Chairman of the board of directors of Rainier Therapeutics, Inc., an oncology biotechnology company focused on late-stage bladder cancer, from June 2024 to January 2024, and served as … WebNov 18, 2024 · Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that it has entered into a definitive agreement with Novo Nordisk under which Novo Nordisk will …
Dicerna Appoints Patrick Gray to Board of Directors to …
WebInvestor Relations. Deciphera Pharmaceuticals (DCPH) is a biopharmaceutical company focused on discovering, developing, and delivering important new medicines to patients for the treatment of cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to execute our strategy to develop ... WebDICERNA PHARMACEUTICALS, INC. (a Delaware corporation) (Pursuant to Sections 228, 242 and 245 of the ... The Board of Directors shall also have the power to adopt, amend, or repeal Bylaws. 2. The directors of the Company need not be elected by written ballot unless the Bylaws so provide. 3. how to say knock it off in spanish
EX-3.1 - SEC
WebJan 24, 2024 · Mr. Buchi, the former president and chief executive officer of Cephalon, Inc. and TetraLogic Pharmaceuticals, joined the Dicerna board of directors in August … WebNov 22, 2024 · The transaction was unanimously approved by the Dicerna Board of Directors and the Board of Directors of Novo Nordisk. Novo Nordisk and Dicerna have been parties to a research collaboration since 2024 to discover and develop RNAi therapies using Dicerna’s proprietary GalXC™ RNAi platform technology. The collaboration … WebNov 18, 2024 · The transaction was unanimously approved by the Dicerna Board of Directors and the Board of Directors of Novo Nordisk. ... Dicerna’s RNAi technology platform enables access to intracellular ... how to say kitten in italian